Showing results (1221-1230 of 6,501) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|September 8, 2018
Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapiesAllison S Dobry, Cheryl K Zogg, F Stephen Hodi, et al.Cancer Immunology, Immunotherapy : CII|September 1, 2018
Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lungMatthew P Alexander, Steven N Fiering, Gary R Ostroff, et al.Cancer Immunology, Immunotherapy : CII|September 1, 2018
T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patientAndreas Wieland, Alice O Kamphorst, N Volkan Adsay, et al.Cancer Immunology, Immunotherapy : CII|September 2, 2018
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)Sabine Schmid, Stefan Diem, Qiyu Li, et al.Cancer Immunology, Immunotherapy : CII|June 6, 2019
PLAC1: biology and potential application in cancer immunotherapyJafar Mahmoudian, Roya Ghods, Mahboobeh Nazari, et al.Cancer Immunology, Immunotherapy : CII|June 10, 2019
An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic miceRichard F Jones, Joyce D Reyes, Heather M Gibson, et al.Cancer Immunology, Immunotherapy : CII|October 12, 2018
Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancerWen Zhang, Xu Lu, Peilin Cui, et al.Cancer Immunology, Immunotherapy : CII|April 12, 2019
Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinomaShuo Liu, Zhen Han, Anna L Trivett, et al.Cancer Immunology, Immunotherapy : CII|September 28, 2021
Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signaturesYvonne H F Teng, Hong Sheng Quah, Lisda Suteja, et al.Cancer Immunology, Immunotherapy : CII|October 18, 2019
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccineCaterina Lapenta, Simona Donati, Francesca Spadaro, et al.Pageof 651